Stock Alerts
FONT-SIZE Plus   Neg
Share SHARE

Halozyme Therapeutics Inc. (HALO) Climbed Sharply Following Upgrade

RELATED NEWS
Trade HALO now with 

BMO Capital Markets upgraded its rating on shares of Halozyme Therapeutics Inc. (HALO: Quote) Monday to "Outperform" from "Market Perform."

Halozyme Therapeutics gapped up sharply Monday and climbed throughout the first 2 hours of trade. The stock finished up by 1.13 at $8.34 on above average volume and leaped to nearly a 4-month high.

Click here to receive FREE breaking news email alerts for Halozyme Therapeutics, Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

comments powered by Disqus